NCT07811726: A Phase 2 Study of NT-101 Topical in Patients With Wet AMD
- State
- Under way
- Phase
- Phase 2
- People
- 66 planned
- Started
- 11 Jun 2026
- Primary completion
- 28 Feb 2028
- Arms
- NT-101 High Dose (0.2 mM)
- Results
- None posted
- 11 Jun 2026: Trial started
- 10 Sep 2026: Trial registered